C12N 2710/22022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2710/22022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 97 US grants and 123 published applications in this corpus.
Search patents in C12N- Granted patents
- 97
- Published applications
- 123
- Assignees
- 102
- Inventors
- 302
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 7 | 0 |
| 1998 | 4 | 0 |
| 1999 | 4 | 0 |
| 2000 | 3 | 0 |
| 2001 | 3 | 0 |
| 2002 | 3 | 9 |
| 2003 | 1 | 6 |
| 2004 | 3 | 12 |
| 2005 | 0 | 5 |
| 2006 | 5 | 5 |
| 2007 | 1 | 5 |
| 2008 | 2 | 4 |
| 2009 | 6 | 7 |
| 2010 | 6 | 3 |
| 2011 | 4 | 6 |
| 2012 | 2 | 5 |
| 2013 | 3 | 3 |
| 2014 | 4 | 9 |
| 2015 | 3 | 3 |
| 2016 | 0 | 5 |
| 2017 | 4 | 2 |
| 2018 | 5 | 6 |
| 2019 | 3 | 4 |
| 2020 | 1 | 3 |
| 2021 | 3 | 4 |
| 2022 | 3 | 2 |
| 2023 | 2 | 9 |
| 2024 | 0 | 2 |
| 2025 | 1 | 2 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Vaccine for preventing and treating Merkel cell carcinoma28 Jul 2026US 12,691,168 B2Advaccine (Suzhou) Biopharmaceuticals Co. Ltd.
- Nucleic acid origami structure encapsulated by capsid units27 May 2025US 12,312,594 B2Geza Ad Ltd.
- Cartilage-derived mesenchymal cell lines27 Jun 2023US 11,685,898 B2Rhode Island Hospital
- Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases21 Mar 2023US 11,608,372 B2Neurimmune Holding AG
- Conjugates enhancing total cellular accumulation7 Jun 2022US 11,352,437 B2Defence Therapeutics Inc.
- Chimeric invasin system5 Mar 2026US 2026/0062730 A1SiVEC Biotechnologies LLC
- Method for producing immortalized cell1 Jan 2026US 2026/0002127 A1Kitayama Labes Co., Ltd.
- Fusion protein for inducing immune response and treating cancer24 Jul 2025US 2025/0235523 A1Taivital Biopharmaceutical Co. Ltd
- Therapeutic nucleic acids, peptides and uses i12 Jun 2025US 2025/0188137 A1
- Person-tailored t cell composition targeting merkel cell carcinoma1 Aug 2024US 2024/0252644 A1Danmarks Tekniske Universitet
Most cited
By later US patents
- Self-assembling polynucleotide delivery system comprising dendrimer polycations110US 5,661,025 A1997
- Transgenic animal model system for human cutaneous melanoma104US 5,550,316 AFox Chase Cancer Center · 1996
- Transgenic animal models for thrombocytopenia70US 5,489,743 AAmgen Inc. · 1996
- Self-assembling polynucleotide delivery system comprising dendrimer polycations47US 6,113,946 AThe Regents of the University of California · 2000
- Immobilization of biologically active molecules by changing the Oxidation state of a chelated transition metal ion42US 5,439,829 AEli Lilly and Company · 1995